Risk factors associated with adverse drug events among older adults in emergency department.
暂无分享,去创建一个
David Hung-Tsang Yen | Liang-Kung Chen | Liang‐Kung Chen | Chen-Chang Yang | Yen-Chia Chen | Ju-Sing Fan | Min-Hui Chen | Teh-Fu Hsu | Hsien-Hao Huang | Kuo-Wei Cheng | Chun-I Huang | Teh-Fu Hsu | Chen-Chang Yang | Hsien-Hao Huang | Yen-Chia Chen | Min-hui Chen | D. Yen | Ju-Sing Fan | K.‐W. Cheng | Chun‐I. Huang
[1] M. Afilalo,et al. Emergency physician recognition of adverse drug-related events in elder patients presenting to an emergency department. , 2005, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[2] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[3] P. Barach,et al. Clarifying Adverse Drug Events: A Clinician's Guide to Terminology, Documentation, and Reporting , 2004, Annals of Internal Medicine.
[4] I. Edwards,et al. Adverse drug reactions: definitions, diagnosis, and management , 2000, The Lancet.
[5] C. Holman,et al. Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003. , 2007, British journal of clinical pharmacology.
[6] J. Avorn,et al. Drug prescribing for the elderly. , 1986, Archives of internal medicine.
[7] Paula Rochon,et al. Improving the quality of medication use in elderly patients: a not-so-simple prescription. , 2002, Archives of internal medicine.
[8] D. Greenblatt,et al. A method for estimating the probability of adverse drug reactions , 1981, Clinical pharmacology and therapeutics.
[9] A. Flahault,et al. Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. , 1993, Journal of clinical epidemiology.
[10] K. Brune,et al. Cytochrome P450 Polymorphisms in Geriatric Patients , 2005, Drugs & aging.
[11] P. Neuvonen,et al. Drug-related deaths in a university central hospital , 2002, European Journal of Clinical Pharmacology.
[12] Daniel J. Kent,et al. A pharmacist-based screening program of octogenarians starting new medications. , 2003, Journal of managed care pharmacy : JMCP.
[13] D. L. Le Couteur,et al. Aging Biology and Geriatric Clinical Pharmacology , 2004, Pharmacological Reviews.
[14] M. Beers,et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. , 2003, Archives of internal medicine.
[15] S. Yusuf,et al. Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial , 2001, Annals of Internal Medicine.
[16] F. Lu,et al. Use of the Beers Criteria to Predict Adverse Drug Reactions Among First‐Visit Elderly Outpatients , 2005, Pharmacotherapy.
[17] Erratum to: Adverse Drug Reactions and Impaired Renal Function in Elderly Patients Admitted to the Emergency Department , 2013, Drugs & Aging.
[18] D. Pollock,et al. Emergency department visits for outpatient adverse drug events: demonstration for a national surveillance system. , 2005, Annals of emergency medicine.
[19] J. de Lemos,et al. Emergency hospitalizations for adverse drug events. , 2012, The New England journal of medicine.
[20] G. Trifirò,et al. Adverse drug events in emergency department population: a prospective Italian study , 2005, Pharmacoepidemiology and drug safety.
[21] C. Bénichou. Criteria of drug-induced liver disorders. Report of an international consensus meeting. , 1990, Journal of hepatology.
[22] H. Sox,et al. Clinical prediction rules. Applications and methodological standards. , 1985, The New England journal of medicine.
[23] Matthew H Samore,et al. Risk Factors for Adverse Drug Events: A 10-Year Analysis , 2005, The Annals of pharmacotherapy.
[24] S. Haider,et al. Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992 - 2002. , 2007, International journal of clinical pharmacology and therapeutics.
[25] M. Ducharme,et al. Drug-Induced Alterations in Serum Creatinine Concentrations , 1993 .
[26] U. Bergman,et al. Adverse Drug Reactions and Impaired Renal Function in Elderly Patients Admitted to the Emergency Department , 2009, Drugs & aging.
[27] K. Johnell,et al. Inappropriate Drug Use in the Elderly: a Nationwide Register-Based Study , 2007, The Annals of pharmacotherapy.
[28] D. Bates,et al. Risk Factors for Adverse Drug Events Among Older Adults in the Ambulatory Setting , 2004, Journal of the American Geriatrics Society.
[29] John W Hafner,et al. Adverse drug events in emergency department patients. , 2002, Annals of emergency medicine.
[30] C. Richards,et al. Medication Use Leading to Emergency Department Visits for Adverse Drug Events in Older Adults , 2007, Annals of Internal Medicine.
[31] E. Eldesoky,et al. Pharmacokinetic-Pharmacodynamic Crisis in the Elderly , 2007, American journal of therapeutics.
[32] J. Rothschild,et al. Analysis of risk factors for adverse drug events in critically ill patients* , 2012, Critical care medicine.
[33] Graziano Onder,et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. , 2010, Archives of internal medicine.
[34] F. Haramburu,et al. Does age increase the risk of adverse drug reactions? , 2002, British journal of clinical pharmacology.
[35] D. Bates,et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. , 2003, JAMA.
[36] Brenda Tipper,et al. The impact of polypharmacy on the health of Canadian seniors. , 2012, Family practice.
[37] D. Bates,et al. Risk factors for adverse drug events among nursing home residents. , 2001, Archives of internal medicine.
[38] J K McLaughlin,et al. Selection of controls in case-control studies. I. Principles. , 1992, American journal of epidemiology.
[39] J K McLaughlin,et al. Selection of controls in case-control studies. III. Design options. , 1992, American journal of epidemiology.
[40] E. Oren,et al. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. , 2001, JAMA.
[41] C. Richards,et al. Emergency Hospitalization for Adverse Drug Events in Older Americans , 2012 .
[42] Y. Chen,et al. Detection of patients presenting with adverse drug events in the emergency department , 2012, Internal medicine journal.
[43] C. Richards,et al. Emergency hospitalizations for adverse drug events in older Americans. , 2011, The New England journal of medicine.
[44] U. Meyer. Pharmacogenetics and adverse drug reactions , 2000, The Lancet.
[45] S. Schroeder,et al. How Many Hours Is Enough? An Old Profession Meets a New Generation , 2004, Annals of Internal Medicine.
[46] M. Gallo,et al. Regional surveillance of emergency-department visits for outpatient adverse drug events , 2009, European Journal of Clinical Pharmacology.
[47] U. Sarkar,et al. Adverse drug events in U.S. adult ambulatory medical care. , 2011, Health services research.